Afecta Pharmaceuticals
Phase 1Afecta Pharmaceuticals develops novel small molecule therapeutics targeting oncology and inflammatory diseases.
Founded
2016
Focus
Small Molecules
About
Afecta Pharmaceuticals develops novel small molecule therapeutics targeting oncology and inflammatory diseases.
Funding History
2Total raised: $37M
Series A$32MRA Capital ManagementNov 15, 2022
Seed$5MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2016
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile